These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 956150)

  • 1. Fluorometric method for assay of kallikrein-like arginine esterases.
    Matsuda Y; Moriya H; Moriwaki C; Fujimoto Y; Matsuda M
    J Biochem; 1976 Jun; 79(6):1197-200. PubMed ID: 956150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of arginine esterase of various kallikrein preparations on gellified electrophoretic media.
    Fujimoto Y; Moriya H; Yamaguchi K; Moriwaki C
    J Biochem; 1972 Apr; 71(4):751-4. PubMed ID: 4339527
    [No Abstract]   [Full Text] [Related]  

  • 3. Kallikrein in granules of a salivary gland.
    Erdös EG; Tague LL; Miwa I
    Proc West Pharmacol Soc; 1968; 11():26-8. PubMed ID: 5306811
    [No Abstract]   [Full Text] [Related]  

  • 4. Localization of kallikrein and its relation to other trypsin-like esterases in the rat pancreas. A comparison with the submandibular gland.
    Orstavik TB; Glenner GG
    Acta Physiol Scand; 1978 Aug; 103(4):384-93. PubMed ID: 362824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation from a salivary gland of granules containing renin and kallikrein.
    Chiang TS; Erdös EG; Miwa I; Tague LL; Coalson JJ
    Circ Res; 1968 Oct; 23(4):507-17. PubMed ID: 4300394
    [No Abstract]   [Full Text] [Related]  

  • 6. A new sensitive assay method of kallikrein-like arginine-esterases.
    Moriya H; Todoki N; Moriwaki C; Hojima Y
    J Biochem; 1971 Apr; 69(4):815-7. PubMed ID: 5572811
    [No Abstract]   [Full Text] [Related]  

  • 7. Action of hog pancreatic kallikrein on synthetic substrates and its some other enzymatic properties.
    Takami T
    J Biochem; 1969 Nov; 66(5):651-8. PubMed ID: 5358625
    [No Abstract]   [Full Text] [Related]  

  • 8. Kinetic peculiarities of human tissue kallikrein: 1--substrate activation in the catalyzed hydrolysis of H-D-valyl-L-leucyl-L-arginine 4-nitroanilide and H-D-valyl-L-leucyl-L-lysine 4-nitroanilide; 2--substrate inhibition in the catalyzed hydrolysis of N alpha-p-tosyl-L-arginine methyl ester.
    Sousa MO; Miranda TL; Maia CN; Bittar ER; Santoro MM; Figueiredo AF
    Arch Biochem Biophys; 2002 Apr; 400(1):7-14. PubMed ID: 11913965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on urinary kallikreins. I. Purification and characterization of human urinary kallikreins.
    Matsuda Y; Miyazaki K; Moriya H; Fujimoto Y; Hojima Y; Moriwaki C
    J Biochem; 1976 Oct; 80(4):671-9. PubMed ID: 1087637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for an androgen-dependent urinary arginine esterase in the rat: separation from other urinary arginine esterases including kallikrein.
    McPartland RP; Sustarsic DL; Rapp JP
    Endocrinology; 1981 May; 108(5):1634-8. PubMed ID: 6908558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens.
    Maier M; Austen KF; Spragg J
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):3928-32. PubMed ID: 6575386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic method for the determination of the esterase activity of subtilisin and kallikrein.
    Pietta P; Mauri P; Pace M
    J Chromatogr; 1988 Jun; 441(2):431-5. PubMed ID: 3045140
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methodologic approaches to the study of the kallikrein-kinin system in myocardial infarct].
    Gomazkov OA; Komissarova NV; Bol'shakova LV; Teplova NN
    Kardiologiia; 1972 Jun; 12(6):25-31. PubMed ID: 4538225
    [No Abstract]   [Full Text] [Related]  

  • 14. Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosis.
    Goldsmith GH; Stern RC; Saito H; Ratnoff OD
    J Lab Clin Med; 1977 Jan; 89(1):131-4. PubMed ID: 830773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increases in plasma kallikrein-like and pancreas kallikrein-like substances after administration of pancreas or plasma kallikrein.
    Naito SI; Tanaka S
    Arzneimittelforschung; 1983; 33(7):952-7. PubMed ID: 6556070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.
    Harpel PC
    J Clin Invest; 1971 Oct; 50(10):2084-90. PubMed ID: 5165598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of cat submaxillary kallikrein.
    Fukuoka Y; Hojima Y; Miyaura S; Moriwaki C
    J Biochem; 1979 Feb; 85(2):549-57. PubMed ID: 422546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylactic release of a basophil kallikrein-like activity. I. Purification and characterization.
    Newball HH; Berninger RW; Talamo RC; Lichtenstein LM
    J Clin Invest; 1979 Aug; 64(2):457-65. PubMed ID: 37257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kinetics of hydrolysis of some extended N-aminoacyl-L-arginine methyl esters by human plasma kallikrein. Evidence for subsites S2 and S3.
    Levison PR; Tomalin G
    Biochem J; 1982 Apr; 203(1):149-53. PubMed ID: 6921035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat submandibular gland kallikreins: purification and cellular localization.
    Brandtzaeg P; Gautvik KM; Nustad K; Pierce JV
    Br J Pharmacol; 1976 Feb; 56(2):155-67. PubMed ID: 1252668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.